Radiotherapy Alone for Non-Small Cell Lung Carcinoma Five-year disease-free survival and patterns of failure

References

• Stanley K E. Lung cancer and tobacco: A global problem. Cancer Detect Prevent 1986; 9: 83–9
   PubMedGoogle Scholar
• Horn J WW, Kessler L G. Falling rates of lung cancer in men in the United States. Lancet 1986; 1: 425–6
   PubMed Web of Science ®Google Scholar
• Enstrom J E, Austin D F. Interpreting cancer survival rates. Science 1977; 195: 847–51
   PubMed Web of Science ®Google Scholar
• Palmer M H, O'Sullivan B, Steele R, Mackillop W J. Controversies in the management of non small cell lung cancer: the results of an expert surrogate study. Radiother Oncol 1990; 19: 17–28
   PubMed Web of Science ®Google Scholar
• Dillman R O, Seagren S L, Propert K, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med 1990; 323: 940–5
   PubMed Web of Science ®Google Scholar
• Mattson K, Holsti L R, Holsti P, et al. Inoperable non small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477–82
   PubMedGoogle Scholar
• Johnson D H, Einhorn L H, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced unresectable non-small cell lung cancer. Ann Intern Med 1990; 113: 33–8
   PubMed Web of Science ®Google Scholar
• Payne D G. Non-small cell lung cancer: should unresectable stage III patients routinely receive high dose radiation therapy? J Clin Oncol 1988; 6: 552–8
   Google Scholar
• Zhang H X, Yin W B, Zhang L J, et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 1989; 14: 89–94
   PubMed Web of Science ®Google Scholar
• Nordijk E M, Poest Clemens E, Hermans J, Wever A M, Leer J W. Radiotherapy as an alternative to surgery in elderly patients with resectable cancer. Radiother Oncol 1988; 13: 83–9
   PubMed Web of Science ®Google Scholar
• Cox J D, Barder-Derus S, Hartz A J, et al. Is adenocarcinoma/large cell carcinoma the most radiocurable type of cancer of the lung? Int J Radiat Oncol Biol Phys 1986; 12: 1801–5
   Google Scholar
• Macejewski B, Taylor J M, Withers H R. Alpha/beta and the importance of the size of dose per fraction for late complications in supraglottic larynx. Radiother Oncol 1986; 7: 323–6
   PubMed Web of Science ®Google Scholar
• American Joint Committee for Cancer Staging and End Results Reporting. Manual for staging cancer. The American Joint Committee, Chicago 1980
   Google Scholar
• Emami B, Perez C A. Carcinoma of the lung. Principles and practice of radiation oncology, C A Perez, L W Brady. JB Lippincott Company. 1987; 650–99
   Google Scholar
• Talton B M, Constable W C, Kersh C R. Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1990; 19: 15–21
   PubMed Web of Science ®Google Scholar
• Reddy S P, Marks J E. Total atelectasis of the lung secondary to malignant airway obstruction. Response to radiation therapy. Am J Clin Oncol 1990; 13: 394–400
   PubMed Web of Science ®Google Scholar
• Likich J, Chaffey J, Neptune W. Concomitant 5-fluorouracil and high dose radiation for stage III non-small cell lung cancer. Cancer 1990; 64: 1021–5
   Web of Science ®Google Scholar
• Salloum J. Radiation therapy a good alternative for inoperable NSCLC. J Miss State Med Assoc 1990; 31: 295–7
   PubMedGoogle Scholar
• Fowler J F. How worthwhile are short schedules in radiotherapy? A series of explanatory calculations. Radiother Oncol 1990; 18: 165–81
   PubMed Web of Science ®Google Scholar
• Saunders M I, Dische S. Continuous hyperfractionated accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1990; 19: 1211–5
   PubMed Web of Science ®Google Scholar
• Cox J D, Azarnia N, Bydhardt R W, Shin K H, Emami B, Pajak T F. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60–79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favourable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83–11. J Clin Oncol 1990; 8: 1543–55
   PubMed Web of Science ®Google Scholar
• Cox J D, Azarnia N, Bydhardt R W, Shin K H, Emami B, Perez C A. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991; 20: 7–12
   PubMed Web of Science ®Google Scholar
• Rivier A, Abouz D, Ayela P, et al. Results of a phase II study of the combination of cis-platinum and 5FU in epidermoid or undifferentiated large cell bronchial cancer. Bull Cancer 1989; 76: 1095–102
   PubMedGoogle Scholar
• vanHarskamp G, Boven E, Vermorken J B, et al. Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer. Int J Radiat Biol Phys 1987; 13: 1735–8
   PubMed Web of Science ®Google Scholar